Wireva

Health Canada approves Eli Lilly’s daily GLP-1 weight-loss pill Foundayo

Health Canada has authorized Eli Lilly’s Foundayo, a daily oral GLP-1 medication for adults with obesity or overweight with a related health problem, and the company expects it in pharmacies in January.

Health Canada approves Eli Lilly’s GLP-1 pill for weight loss
Health Canada approves Eli Lilly’s daily GLP-1 weight-loss pill Foundayo
photographer not idenfied · Public domain · rights

This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.

Monitoring item. The full text is not distributed. Extract and source below.

Health Canada has authorized Eli Lilly’s Foundayo, a daily oral GLP-1 medication for adults with obesity or overweight with a related health problem, and the company expects it in pharmacies in January.